Recent Press Releases

U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C

NORTH CHICAGO, Ill., April 24, 2015 -- AbbVie (NYSE: ABBV) has announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) and granted priority review for...

Teva and Active Biotech Announce First Patient Enrolled in Phase II Study Evaluating Laquinimod for Primary Progressive MS

JERUSALEM & LUND, Sweden--Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) and Active Biotech (NASDAQ OMX NORDIC:ACTI) today announced the first patient has been enrolled in the study A...

Lysogene appoints Annette Clancy as Chair of the Board

Experienced pharmaceutical and biotech executive to chair the gene therapy company's board FOR IMMEDIATE RELEASE Paris, France—April 20, 2015— Annette Clancy has been appointed Chair of...

Vanda Pharmaceuticals, Inc. (VNDA) Announces The Appointment Of Chief Commercial Officer

WASHINGTON, April 20, 2015 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that it has named Tom Gibbs as Senior Vice President, Chief Commercial Officer of the...

OpGen Appoints Industry Veterans Dr. Kevin Krenitsky As President And Timothy Dec As Interim Chief Financial Officer

GAITHERSBURG, Md., April 20, 2015 /PRNewswire/ -- OpGen, Inc., a molecular testing and bioinformatics company, today announced the expansion of its executive management team with the appointments of...

Pipeline Advancements and Asset Acquisitions Fueled Mid-Cap Biotech Research and Development Spend in 2014, says GlobalData

LONDON, UK (GlobalData), 23 April 2015 - The combined spend on research and development (R&D) for the peer group of 35 mid-cap biotech companies increased by nearly $2 billion to reach a total of...

Keryx Biopharmaceuticals Appoints John F. Neylan, MD, As Chief Medical Officer

BOSTON and NEW YORK, April 23, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company"), today announced the appointment of John F. Neylan, MD to the newly...

BioSpecifics Technologies Corporation (BSTC) Announces Appointment Of Jennifer Chao and Jyrki Mattila, M.D., Ph.D. To Board Of Directors

LYNBROOK, N.Y., April 22, 2015 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced the...

AVEO Oncology (AVEO) Names Keith S. Ehrlich As Chief Financial Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ:AVEO) today announced the appointment of Keith S. Ehrlich to the position of chief financial officer. In this role, Mr. Ehrlich will be...

Intellia Therapeutics Announces Dr. Jennifer Doudna And Dr. Derrick Rossi To Join Company

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Intellia Therapeutics, founded to develop curative medicines utilizing CRISPR/Cas9 for gene editing and repair, announced today that Jennifer Doudna, PhD, and...

Intellia Therapeutics Announces The Appointment Of Dr. Sapna Srivastava As Chief Finance & Strategy Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Intellia Therapeutics, founded to develop curative medicines utilizing CRISPR/Cas9 technology for gene editing and repair, announced today the appointment of Dr....

La Jolla Pharmaceutical Company (LJPC) Announces Additions To LJPC-401 Advisory Board

SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in...

Ritter Pharmaceuticals, Inc. Names Gastroenterology Industry Veteran Gerald T. Proehl To Its Board Of Directors

LOS ANGELES--(BUSINESS WIRE)--Ritter Pharmaceuticals, Inc., a privately held pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat...

Xenetic Biosciences Announces Board Change

LEXINGTON, Mass., April 21, 2015 (GLOBE NEWSWIRE) -- Xenetic Biosciences, Inc. (OTCBB:XBIO), a biopharmaceutical company focused on developing next-generation biologic drugs and novel oncology...

Pain Therapeutics (PTIE) Announces Appointment Of Senior Vice President, Regulatory Affairs

AUSTIN, Texas, April 23, 2015 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE), a clinical-stage biopharmaceutical company, announced the appointment of Michael Marsman, Pharm.D., as Senior...

KaloBios Pharmaceuticals, Inc. (KBIO) Elects Ronald A. Martell To Board Of Directors

SOUTH SAN FRANCISCO, Calif., April 22, 2015 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced the election of veteran biopharmaceutical industry executive, Ronald A....

NeoGenomics, Inc. (NGNM.OB) Announces Promotions

FT. MYERS, Fla., April 23, 2015 /PRNewswire/ -- NeoGenomics, Inc. (NASDAQ: NEO),a leading provider of cancer-focused genetic testing services, announced today several promotions within the...

Recipharm AB Appoints New General Manager For Recipharm Italia S.P.A

Recipharm, the leading contract development and manufacturing organisation, has today announced that Giorgio Bruno has been appointed General Manager of Recipharm Italia S.p.A. In this role, he will...

AstraZeneca enters strategic immuno-oncology collaboration with Celgene Corporation to develop PD-L1 inhibitor programme for patients with serious blood cancers

AstraZeneca and MedImmune, the Company's global biologics research and development arm, today announced that they have entered into an exclusive collaboration agreement with Celgene Corporation,...

AstraZeneca and Innate Pharma announce global co-development and commercialisation collaboration for IPH2201 in immuno-oncology

AstraZeneca and MedImmune, the Company's global biologics research and development arm, today announced that they have entered into a collaboration to accelerate and broaden the development of...